News and Trends 4 Sep 2024
2024: a year of breakthroughs for endometrial cancer?
New treatments have been approved by regulators for endometrial cancer, which are regarded as major therapeutic breakthroughs.
Regulatory approval
- Latest Posts
Navigating your path to globalization: Untangling the regulatory maze of the Advanced Therapies supply chain
Discover how Cryoport Systems can help you navigate EMEA regulations and manage the supply chain complexities for advanced therapies.
News and Trends 13 Aug 2024
Biologics vs. drugs: What does Ipsen’s lost case against the FDA mean for the industry?
Ipsen has lost a court case against U.S. regulators to have its blockbuster cancer medication Somatuline Depot regarded as a biologic instead of a drug.
News and Trends 1 Aug 2024
European regulators reject Alzheimer’s drug Leqembi: is it downhill from here?
European regulators have now refused to market the Alzheimer’s drug Leqembi after it was approved by the FDA last year.
More News! 23 Jul 2024
First AKT-targeting drug capivasertib to hit the market, could it open the door for more?
As AstraZeneca and Astex’s capivasertib gains market presence in breast cancer, could it be the time for AKT inhibitors? Let’s find out!
In Depth 27 Jun 2024
The 2024 drug approval list: Eight new treatments you should know about
In this article, we take a look at eight much-anticipated drugs that have been approved by regulators so far this year.
ADVERTISEMENT
ADVERTISEMENT
In Depth 19 Jun 2024
MASH candidates make a splash after first drug approval
The first drug to treat MASH, a potentially life-threatening liver disease, was approved this year. More recent advancements bring hope to patients.
Expert Advice 14 Jun 2024
Biotech valuation multiples: how to value a biotech company?
How do biotech valuations based on multiples work? Experts share their most reliable methods to find the right price for a company’s stocks.
In Depth 5 Jun 2024
Evolving standards of care: new treatments for cervical cancer
New treatments for cervical cancer aim to broaden therapeutic options, and improve current standards of care for patients.
In Depth 15 Apr 2024
Does the FDA need to tighten its grip on drug trials in the U.S.?
Studies suggest that the FDA has been less rigorous with its drug approval standards. We looked at the current state of the approval process.
In Depth 21 Mar 2024
Biotech in France: What’s holding back progress and how to move forward?
Explore the latest insights from France Biotech’s ‘Panorama France HealthTech’ report, uncovering key insights of the French biotech sector.
Expert Advice 15 Mar 2024
Is biotechnology a good career? Here are the pros and cons
Find out about the pros and cons of pursuing a career in biotechnology, from competitive salaries to dealing with regulatory hurdles.
ADVERTISEMENT
